1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – By Country

2.           Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

4.4         Clinical Trials Phases of Products Offered by Companies

4.5         Candida Specific Marketed Products

5.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Fungal Diseases

5.1.2        Rising Hospital Acquired Fungal Infection

5.2         Market Restraints

5.2.1        Increasing Resistance to Antifungal Drugs

5.2.2        Side Effects of Antifungal Drugs

5.3         Market Opportunities

5.3.1        Increase in R&D Activities and Pipeline of New Drug

5.4         Future Trends

5.4.1        Consolidation of Market

5.5         Impact Analysis

6.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1         Overview

6.2         Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3         Voriconazole

6.3.1        Overview

6.3.2        Middle East & Africa Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4         Liposomal Amphotericin B

6.4.1        Overview

6.4.2        Middle East & Africa Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5         Systemic Oral Azoles

6.5.1        Overview

6.5.2        Middle East & Africa Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6         Topical Antifungal Agents

6.6.1        Overview

6.6.2        Middle East & Africa Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Others

6.7.1        Overview

6.7.2        Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1         Overview

7.2         Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3         Chronic Pulmonary Aspergillosis (CPA)

7.3.1        Overview

7.3.2        Middle East & Africa Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1        Overview

7.4.2        Middle East & Africa Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Gastrointestinal Candidasis

7.5.1        Overview

7.5.2        Middle East & Africa Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Genitourinary Tract Candidasis

7.6.1        Overview

7.6.2        Middle East & Africa Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis

8.1         Overview

8.1.1        Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.2        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.3        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.4        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

8.1.5        South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.5.3          South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.6        Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3          Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.7        UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3          UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.8        Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1          Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2          Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.8.3          Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

9.           Impact of COVID-19 Pandemic on Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market

9.1         Middle East and Africa Impact Assessment of COVID-19 Pandemic

10.        COMPANY PROFILES

10.1      Novartis AG

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Sanofi

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      Pfizer Inc.

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Merck & Co., Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      Bayer AG

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      GlaxoSmithKline plc.

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      Abbott

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Cipla Inc.

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

11.        Appendix

11.1      About the Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             Clinical Trials Phases of Products Offered by Companies

Table 2.             Candida Specific Marketed Products

Table 3.             Clinical cases of Candida auris reported by U.S. states, as of November 30, 2020

Table 4.             Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             South Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027

Table 8.             Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          UAE: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13.          Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 14.          Glossary of Terms, Systemic Aspergillosis And Systemic Candidasis Market

LIST OF FIGURES

Figure 1.           Systemic Aspergillosis And Systemic Candidasis Market Segmentation

Figure 2.           Systemic Aspergillosis And Systemic Candidasis Market, By Country

Figure 3.           Middle East & Africa Systemic Aspergillosis And Systemic Candidasis Market Overview

Figure 4.           Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           PEST Analysis

Figure 7.           Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8.           Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9.           Middle East & Africa Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10.        Middle East & Africa Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Middle East & Africa Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Middle East & Africa Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Middle East & Africa others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15.        Middle East & Africa Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16.        Middle East & Africa Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Middle East & Africa Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Middle East & Africa Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Middle East & Africa others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

Figure 23.        South Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Saudi Arabia: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        UAE: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Rest of Middle East & Africa: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Impact Of COVID-19 Pandemic in Middle East and Africa Market